Article info
Editorial
Ivabradine is cost-effective in the treatment of chronic heart failure
- Correspondence to Professor Stephen Morris, Department of Applied Health Research, University College London, 1-19 Torrington Place, London WC1E 7HB, UK; steve.morris{at}ucl.ac.uk
Citation
Ivabradine is cost-effective in the treatment of chronic heart failure
Publication history
- Received March 19, 2014
- Accepted March 22, 2014
- First published April 15, 2014.
Online issue publication
June 09, 2014
Article Versions
- Previous version (15 April 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions